SCHEMBL192450

SCHEMBL192450

FC(F)(F)c1ccccc1Sc1ccnc(Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 3/20 0.39
PGR P06401 1/20 0.39
HTR2C P28335 1/20 0.39
HTR6 P50406 1/20 0.39
MAPK14 Q16539 1/20 0.37
NOTUM Q6P988 1/20 0.36
GRM5 P41594 1/20 0.35
LRRK2 Q5S007 1/20 0.35
TRPA1 O75762 1/20 0.35
KDR P35968 1/20 0.35
S1PR1 P21453 1/20 0.35
S1PR3 Q99500 1/20 0.35
GRM4 Q14833 1/20 0.35
AKR1C3 P42330 1/20 0.34
AKR1C2 P52895 1/20 0.34
ITGB2 P05107 2/20 0.34
ICAM1 P05362 2/20 0.34
ITGAL P20701 2/20 0.34
BRAF P15056 1/20 0.34
SMARCA2 P51531 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL191204 0.79 HPGD (0.44) GRM5TRPA1
SCHEMBL191123 0.76 AR (0.41) ARHTR2CHTR6MAPK14GRM5
SCHEMBL190818 0.74 SIRT2 (0.44) GRM5TRPA1
SCHEMBL191141 0.73 TRPA1 (0.47) HTR2CHTR6GRM5TRPA1
SCHEMBL23994244 0.73 AKR1C3 (0.50) ARTRPA1S1PR1S1PR3AKR1C3
SCHEMBL191746 0.73 ALDH1A1 (0.40) NOTUMGRM5TRPA1ITGAL
SCHEMBL30224509 0.73 AKR1C3 (0.50) ARTRPA1S1PR1S1PR3AKR1C3
SCHEMBL191108 0.73 ITGB2 (0.39) GRM5TRPA1ITGB2ICAM1ITGAL
SCHEMBL8863558 0.72 NOTUM (0.45) ARPGRHTR2CHTR6NOTUM
SCHEMBL29484715 0.72 NOTUM (0.45) ARPGRHTR2CHTR6NOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1986645-B1 GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC (US) 2012-01-04 EP disclosed
US-8022222-B2 Glucokinase activators ARRAY BIOPHARMA, INC. (US) 2011-09-20 US disclosed
US-20090247526-A1 GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC. (US) 2009-10-01 US disclosed
EP-1986645-A1 GLUCOKINASE ACTIVATORS Array Biopharma, Inc. (US) 2008-11-05 EP disclosed
WO-2007089512-A1 GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC. (US) 2007-08-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247526-A1 GLUCOKINASE ACTIVATORS GCKR, GCK, GALK1 AR 4276/4885PGR 3953/4885HTR2C 4737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.